Close Menu

NEW YORK – Personalis reported Monday that it anticipates an 11 percent increase in its 2020 fourth quarter revenues compared to the same period of 2019.

For the quarter ended Dec. 31, 2020, the Menlo Park, California-based precision oncology and population genomics company estimated earnings of $20.2 million in the fourth quarter of 2020 compared with $18.2 million in Q4 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.